23693

    544172

    INDGN

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    INDEGENE LIMITED Share Price Today

    INDEGENE LIMITED is currently trading at ₹495, down by ₹13.29 from the previous close. The stock touched an intraday high of ₹511.30 and a low of ₹492.00 during the latest trading session. Over the past one year, INDEGENE LIMITED has delivered a loss of 10.23%, while the stock has declined 2.24% in the last one month.

    INDEGENE LIMITED performance

    Today’s low Today’s high
    ₹ 492.00 ₹ 511.30
    ₹ 494.15
    52 week low 52 week high
    ₹ 414.00 ₹ 596.80
    ₹ 494.15
    Open Price ₹ 511.25
    Prev. Close ₹ 508.30
    Volume (Shares) 301218.00
    Total traded value ₹ 1488.46
    Upper Circuit ₹ 609.95
    Lower Circuit ₹ 406.65
    info

    Investment Returns

    Over 1 Month -2.24% Over 3 Months 8.09% Over 6 Months -2.39% Over 1 Year -10.23%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    INDEGENE LIMITED fundamentals


    • Market cap (Cr) 11,904.70
    • P/E Ratio (TTM) 57.82
    • Beta 0.78
    • Book Value / share 86.36
    • Return on equity 12.76%
    • EPS (TTM) 8.80
    • Dividend yield 0.44%
    • Net profit/quarter (Cr) 72.10
    info icon alternate text
    • Market cap (Cr) 11,907.10
    • P/E Ratio (TTM) 57.82
    • Beta 0.74
    • Book Value / share 86.36
    • Return on equity 12.76%
    • EPS (TTM) 8.80
    • Dividend yield 0.44%
    • Net profit/quarter (Cr) 72.10
    info icon alternate text

    INDEGENE LIMITED Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 368.20
    Operating Expense 279.10
    Net Profit 72.10
    Net Profit Margin (%) 19.58
    Earnings Per Share (EPS) 3.00
    EBITDA 109.20
    Effective Tax Rate (%) 24.26
    Particulars DEC 2025 (Values in Cr)
    Revenue 290.10
    Operating Expense 263.70
    Net Profit 34.80
    Net Profit Margin (%) 11.99
    Earnings Per Share (EPS) 1.45
    EBITDA 60.30
    Effective Tax Rate (%) 28.97
    Particulars SEP 2025 (Values in Cr)
    Revenue 306.70
    Operating Expense 246.70
    Net Profit 59.90
    Net Profit Margin (%) 19.53
    Earnings Per Share (EPS) 2.50
    EBITDA 88.10
    Effective Tax Rate (%) 22.70
    Particulars JUN 2025 (Values in Cr)
    Revenue 255.60
    Operating Expense 227.89
    Net Profit 45.10
    Net Profit Margin (%) 17.64
    Earnings Per Share (EPS) 1.88
    EBITDA 68.80
    Effective Tax Rate (%) 24.58
    Particulars MAR 2025 (Values in Cr)
    Revenue 266.70
    Operating Expense 235.50
    Net Profit 54.20
    Net Profit Margin (%) 20.32
    Earnings Per Share (EPS) 2.26
    EBITDA 74.80
    Effective Tax Rate (%) 18.37
    Particulars MAR 2026 (Values in Cr)
    Revenue 1220.60
    Operating Expense 1017.50
    Net Profit 211.90
    Net Profit Margin (%) 17.36
    Earnings Per Share (EPS) 8.83
    EBITDA 326.40
    Effective Tax Rate (%) 24.69
    Particulars MAR 2025 (Values in Cr)
    Revenue 1093.60
    Operating Expense 945.50
    Net Profit 181.30
    Net Profit Margin (%) 16.57
    Earnings Per Share (EPS) 7.64
    EBITDA 270.90
    Effective Tax Rate (%) 23.98
    Particulars MAR 2024 (Values in Cr)
    Revenue 1045.60
    Operating Expense 915.30
    Net Profit 137.90
    Net Profit Margin (%) 13.18
    Earnings Per Share (EPS) 6.22
    EBITDA 218.29
    Effective Tax Rate (%) 23.64
    Particulars MAR 2023 (Values in Cr)
    Revenue 1005.70
    Operating Expense 865.90
    Net Profit 130.20
    Net Profit Margin (%) 12.94
    Earnings Per Share (EPS) 5.89
    EBITDA 214.70
    Effective Tax Rate (%) 26.27
    Particulars MAR 2022 (Values in Cr)
    Revenue 836.70
    Operating Expense 694.60
    Net Profit 132.70
    Net Profit Margin (%) 15.85
    Earnings Per Share (EPS) 758.28
    EBITDA 196.50
    Effective Tax Rate (%) 21.89
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 109.17
    ROE % 20.11
    ROCE % 23.31
    Total Debt to Total Equity 0.15
    EBITDA Margin 22.59
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 64.37
    ROE % 27.01
    ROCE % 27.00
    Total Debt to Total Equity 0.40
    EBITDA Margin 22.56
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 48.03
    ROE % 29.12
    ROCE % 29.51
    Total Debt to Total Equity 0.31
    EBITDA Margin 19.69
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 4352.71
    ROE % 34.93
    ROCE % 41.60
    Total Debt to Total Equity 0.11
    EBITDA Margin 18.79
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 2073.47
    ROE % 133.87
    ROCE % 59.18
    Total Debt to Total Equity 0.41
    EBITDA Margin 27.01
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 78.80
    ROE % 12.76
    ROCE % 16.27
    Total Debt to Total Equity 0.02
    EBITDA Margin 24.77
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 42.96
    ROE % 15.77
    ROCE % 19.54
    Total Debt to Total Equity 0.05
    EBITDA Margin 20.88
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 35.91
    ROE % 18.02
    ROCE % 22.85
    Total Debt to Total Equity 0.07
    EBITDA Margin 21.35
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 3250.00
    ROE % 29.36
    ROCE % 34.22
    Total Debt to Total Equity 0.07
    EBITDA Margin 23.49
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 1692.67
    ROE % 96.36
    ROCE % 47.72
    Total Debt to Total Equity 0.12
    EBITDA Margin 35.30
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 374.60
    Total Assets 3325.90
    Total Liabilities 3325.90
    Total Equity 2615.60
    Share Outstanding 23
    Price to Book Ratio 7.34
    Return on Assets (%) 12.22
    Return on Capital (%) 15.55
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 191.00
    Total Assets 2545.60
    Total Liabilities 2545.60
    Total Equity 1429.10
    Share Outstanding 22
    Price to Book Ratio 0.00
    Return on Assets (%) 13.22
    Return on Capital (%) 18.38
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 85.80
    Total Assets 2203.90
    Total Liabilities 2203.90
    Total Equity 1063.80
    Share Outstanding 22
    Price to Book Ratio 0.00
    Return on Assets (%) 12.07
    Return on Capital (%) 18.25
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 517.30
    Total Assets 1353.46
    Total Liabilities 1353.46
    Total Equity 763.90
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 12.17
    Return on Capital (%) 21.07
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 139.90
    Total Assets 596.04
    Total Liabilities 596.04
    Total Equity 333.08
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 25.06
    Return on Capital (%) 41.75
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 163.60
    Total Assets 2149.70
    Total Liabilities 2149.70
    Total Equity 1888.20
    Share Outstanding 23
    Price to Book Ratio 7.34
    Return on Assets (%) 8.43
    Return on Capital (%) 9.6
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 15.60
    Total Assets 1220.30
    Total Liabilities 1220.30
    Total Equity 953.80
    Share Outstanding 22
    Price to Book Ratio 0.00
    Return on Assets (%) 11.30
    Return on Capital (%) 14.46
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 54.00
    Total Assets 1037.70
    Total Liabilities 1037.70
    Total Equity 795.30
    Share Outstanding 22
    Price to Book Ratio 0.00
    Return on Assets (%) 12.54
    Return on Capital (%) 16.37
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 38.80
    Total Assets 850.10
    Total Liabilities 850.10
    Total Equity 650.00
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 15.60
    Return on Capital (%) 20.42
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 18.20
    Total Assets 372.60
    Total Liabilities 372.60
    Total Equity 253.90
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 35.53
    Return on Capital (%) 52.15
    Particulars MAR 2025 (Values in Cr)
    Net Income 539.30
    Cash from Operations 601.90
    Cash from Investing -682.70
    Cash from Financing 287.50
    Net change in Cash 46.70
    Free Cash Flow 631.90
    Particulars MAR 2024 (Values in Cr)
    Net Income 458.60
    Cash from Operations 632.60
    Cash from Investing -327.20
    Cash from Financing -66.20
    Net change in Cash 114.30
    Free Cash Flow 643.30
    Particulars MAR 2023 (Values in Cr)
    Net Income 363.04
    Cash from Operations 238.45
    Cash from Investing -893.34
    Cash from Financing 333.08
    Net change in Cash -430.04
    Free Cash Flow 257.29
    Particulars MAR 2022 (Values in Cr)
    Net Income 226.49
    Cash from Operations 367.38
    Cash from Investing -160.20
    Cash from Financing 233.47
    Net change in Cash 370.31
    Free Cash Flow 392.09
    Particulars MAR 2021 (Values in Cr)
    Net Income 195.84
    Cash from Operations 221.64
    Cash from Investing -24.24
    Cash from Financing -131.50
    Net change in Cash 16.27
    Free Cash Flow 242.25
    Particulars MAR 2025 (Values in Cr)
    Net Income 238.50
    Cash from Operations 199.60
    Cash from Investing -824.70
    Cash from Financing 717.30
    Net change in Cash 21.60
    Free Cash Flow 216.10
    Particulars MAR 2024 (Values in Cr)
    Net Income 180.60
    Cash from Operations 225.50
    Cash from Investing -187.70
    Cash from Financing -15.80
    Net change in Cash -27.30
    Free Cash Flow 235.40
    Particulars MAR 2023 (Values in Cr)
    Net Income 176.60
    Cash from Operations 123.70
    Cash from Investing -47.90
    Cash from Financing -16.90
    Net change in Cash 17.10
    Free Cash Flow 139.50
    Particulars MAR 2022 (Values in Cr)
    Net Income 169.90
    Cash from Operations 74.10
    Cash from Investing -266.70
    Cash from Financing 244.90
    Net change in Cash 16.40
    Free Cash Flow 95.10
    Particulars MAR 2021 (Values in Cr)
    Net Income 159.90
    Cash from Operations 78.90
    Cash from Investing -33.20
    Cash from Financing -37.10
    Net change in Cash -17.00
    Free Cash Flow 97.30
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTERPRISE LT 8897.35 65.40 13.50 127930.24 6680.00 8917.95
    FORTIS MALAR HOSPITALS LIMITED 52.38 23.70 2.85 98.17 40.75 76.00
    SHREE PACETRONIX LTD. 129.50 15.45 2.72 48.56 71.00 283.15
    TRANSGENE BIOTEK LTD. 2.96 0.00 2.67 22.43 1.83 5.26
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTERPRISE LT 8897.35 85.22 12.84 127930.24 6680.00 8917.95
    [-] 0.0 0.0 0.0 0.0 0.0 0.0
    CHENNAI MEENAKSHI MULTISPECIAL 38.43 0.00 -9.35 28.71 30.30 57.48
    KOVAI MEDICAL CENTER & HO 6041.50 27.04 5.00 6609.40 5010.00 6725.00

    INDEGENE LIMITED shareholding pattern

    Holding
    81.43%
    10.26%
    8.29%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    INDEGENE LIMITED Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    494.15 -2.78 redarrow
    red-green-graph indicator
    16 Bearish
    0 Bullish
    • 5 Days 515.00
    • 26 Days 517.90
    • 10 Days 517.90
    • 50 Days 512.60
    • 12 Days 518.40
    • 100 Days 507.60
    • 20 Days 518.60
    • 200 Days 516.70
    512.37 PIVOT
    First Support 500.93 First Resistance 519.73 Second Support 493.57 Second Resistance 531.17 Third Support 482.13 Third Resistance 538.53
    RSI 44.17 ADX 19.49 MACD 0.49 Williams % R -92.72 Commodity Channel Index (CCI) -103.01
    Date 2026-07-03 Week 121987.00 Same Day 261042.00 Month 117546.00
    1 Year 0.78 3 Year 0.86
    Over 1 Month
    -2.24% down
    Over 1 Year
    -10.23% down
    Over 3 Months
    8.09% down
    Over 3 Years
    -3.79% down
    Over 6 Months
    -2.39% down
    Over 5 Years
    0.00% down

    INDEGENE LIMITED Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    13 Jun 2025 2.0 Final 13 Jun 2025 Equity shares
    Dividend date Dividend amount Dividend type Record date Instrument type
    13 Jun 2025 2.0 Final 13 Jun 2025 Equity shares

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Indegene Ltd?

    Answer Field

    Indegene Ltd share price is for NSE ₹ 495.00 & for BSE ₹ 494.25 as on Jul 06 2026 03:29 PM.

    What is the Market Cap of Indegene Ltd Share?

    Answer Field

    The market cap of Indegene Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 06 2026 03:29 PM.

    What is the 52 Week High and Low of Indegene Ltd?

    Answer Field

    The 52 Week High and Low of Indegene Ltd for NSE is ₹ 596.80 and ₹ 414.00 and for BSE is ₹ 596.50 and ₹ 414.90.

    What is 1 year return for Indegene Ltd?

    Answer Field

    The 1 year returns on the stock has been -10.23%.

    What is the P/E Ratio of Indegene Ltd Share?

    Answer Field

    As on Jul 06 2026 03:29 PM the price-to-earnings (PE) ratio for Indegene Ltd share is 57.82.

    What is the PB ratio of Indegene Ltd Share?

    Answer Field

    As on Jul 06 2026 03:29 PM, the price-to-book (PB) ratio for Indegene Ltd share is 86.36.

    How to Buy Indegene Ltd Share?

    Answer Field

    You can trade in Indegene Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Indegene Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Indegene Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Indegene Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |